TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/25 16:11 | 12/3/25 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 3 | P.m | 96 | 5.01 | 0 | 19 | 16 | 141 | D | ||||||||||||||
12/1/25 16:33 | 11/26/25 | QDEL | Quidelortho Corp | Health | Diagn | In Vitro & In Vivo Diagnostic | 4 | 4 | P | 659 | 22.22 | 0 | 30 | 32 | 121 | D | |||||||||||||||
11/17/25 13:12 | 11/17/25 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 3 | 5 | P.d | 147 | 0.5067 | 0 | 289 | 3 | 8,639 | D | ||||||||||||||
11/7/25 12:20 | 11/3/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 1 | 6.25 | 0 | 0 | 56 | 0 | I | ||||||||||||||
9/19/25 17:26 | 9/17/25 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 3 | 3 | P.d | 532 | 0.4500 | 0 | 1,183 | 30 | 5,125 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |